21 CFR § 522.1086 - Guaifenesin solution.

---
identifier: "/us/cfr/t21/s522.1086"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 522.1086 - Guaifenesin solution."
title_number: 21
title_name: "Food and Drugs"
section_number: "522.1086"
section_name: "Guaifenesin solution."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "E"
subchapter_name: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_number: "522"
part_name: "IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 360b."
regulatory_source: "40 FR 13858, Mar. 27, 1975, unless otherwise noted."
cfr_part: "522"
---


# 522.1086 Guaifenesin solution.

(a) *Specifications.* Each milliliter of solution contains 50 milligrams (mg) of guaifenesin and 50 mg of dextrose.

(b) *Sponsors.* See Nos. 037990 and 058198 in § 510.600(c) of this chapter.

(c) *Conditions of use in horses*—(1) *Amount.* Administer 1 milliliter per pound of body weight by rapid intravenous infusion.

(2) *Indications for use.* For use as a skeletal muscle relaxant.

(3) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[79 FR 16189, Mar. 25, 2014, as amended at 86 FR 14820, Mar. 19, 2021]